US Broker Ratings

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring Its 11.61% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the medical devices industry, is capturing investor attention with its attractive growth potential and a solid position in the healthcare..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Biotechnology Leader with 22.91% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) presents a compelling opportunity for investors seeking exposure to the innovative field of biotechnology. With a market capitalization of $52.88 billion, this Cambridge, Massachusetts-based company..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Evaluating the 16.83% Upside Potential in the Biotech Sector

Roivant Sciences Ltd. (NASDAQ: ROIV), a London-based clinical-stage biopharmaceutical company, stands at the frontier of innovative drug discovery and development. With a market capitalization of $15.59 billion, Roivant is making..

Ascendis Pharma A/S (ASND) Investor Outlook: Analyzing a 269% Revenue Growth in the Biotech Space

Ascendis Pharma A/S (NASDAQ: ASND), a cutting-edge player in the biotechnology sector, is captivating investor attention with its remarkable revenue growth of 269.4% amidst an evolving healthcare landscape. Based in..

Danaher Corporation (DHR) Stock Analysis: Why a 14.79% Potential Upside Might Capture Investor Attention

Danaher Corporation (NYSE: DHR) stands as a formidable entity in the healthcare sector, specifically within the diagnostics and research industry. With a significant market capitalization of $161 billion, Danaher has..

DexCom, Inc. (DXCM)

⚠️ No article content returned.

..

STERIS plc (STE) Stock Analysis: 10.73% Potential Upside and Strong Revenue Growth Draw Investors’ Attention

Investors seeking opportunities in the healthcare sector may find STERIS plc (NYSE: STE) an intriguing prospect. With its roots in infection prevention products and services, STERIS serves a vital role..

The Cigna Group (CI) Stock Analysis: A Closer Look at Its 19.5% Potential Upside

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector, commands attention with its robust position in the healthcare plans industry. With a market capitalization of $72.63 billion, Cigna..

AstraZeneca PLC (AZN) Stock Analysis: Strong Buy Ratings and 8.31% Upside Potential

AstraZeneca PLC (AZN) is a powerhouse in the healthcare sector, standing out as a leader in the drug manufacturing industry. With a market capitalization of $283.27 billion, this UK-based biopharmaceutical..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 14.23% Potential Upside in the Healthcare Sector

For investors seeking to expand their portfolios within the healthcare sector, The Ensign Group, Inc. (NASDAQ: ENSG) presents an interesting opportunity. As a leading player in the medical care facilities..

Becton, Dickinson and Company (BDX): Investor Outlook Reveals 4.13% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor attention with its expansive portfolio in medical instruments and supplies. With a market capitalization..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating the Biotech Frontier with a Strong R&D Pipeline and Robust Revenue Growth

Exelixis, Inc. (NASDAQ: EXEL) stands as a formidable player in the biotechnology sector, with a strategic focus on oncology. As a leading innovator in the development of treatments for hard-to-treat..

BioMarin Pharmaceutical Inc. (BMRN): Analyzing a Promising 44.48% Upside with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a major player in the biotechnology sector, is capturing investor attention with its significant growth potential and a robust pipeline of therapies for life-threatening rare..

Cardinal Health (CAH) Stock Analysis: Unpacking Its 6.73% Potential Upside and Robust Revenue Growth

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, has been capturing investor attention with its robust operational performance and promising stock potential. Specializing in medical distribution,..

ICON plc (ICLR) Stock Analysis: Unveiling an 18.76% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), headquartered in Dublin, Ireland, is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. The company offers a comprehensive suite of..

Koninklijke Philips N.V. (PHG) Stock Analysis: Uncovering a 25% Upside Potential in Healthcare Innovation

Investors exploring opportunities in the medical devices industry should take a closer look at Koninklijke Philips N.V. (PHG), a prominent player in the healthcare sector based in the Netherlands. Known..

IDEXX Laboratories (IDXX) Stock Analysis: Examining Growth Potential with a 9.38% Upside

Investors with a keen eye on the healthcare sector should certainly take note of IDEXX Laboratories, Inc. (NASDAQ: IDXX). This industry leader in diagnostics and research, based in the United..

West Pharmaceutical Services, Inc. (WST) Investor Outlook: Navigating a 26.85% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST), a stalwart in the healthcare sector, specializes in medical instruments and supplies, with a market capitalization of $19.61 billion. Headquartered in Exton, Pennsylvania, the..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 3.38% Potential Upside in Healthcare

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a leading player in the global pharmaceutical industry, continues to attract investor attention with its robust market presence and promising growth prospects. Based in..

Tempus AI, Inc. (TEM) Stock Analysis: Unveiling a 39.88% Potential Upside in Healthcare Tech

Tempus AI, Inc. (NASDAQ: TEM) is a burgeoning player in the healthcare technology sector, with a focus on providing cutting-edge health information services. Based in Chicago, Illinois, Tempus AI’s strategic..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds